Atlas Trials

Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer

Clinical trial NCT00005031 · COMPLETED

Trial details

NCT number
NCT00005031
Sponsor
Gynecologic Oncology Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Endometrial Cancer
Start date
2000-08-01
Primary completion
2004-10-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.